[go: up one dir, main page]

BR0111726A - Derivados de biotina - Google Patents

Derivados de biotina

Info

Publication number
BR0111726A
BR0111726A BR0111726-2A BR0111726A BR0111726A BR 0111726 A BR0111726 A BR 0111726A BR 0111726 A BR0111726 A BR 0111726A BR 0111726 A BR0111726 A BR 0111726A
Authority
BR
Brazil
Prior art keywords
biotin derivatives
body fluids
extracorporeal
toxic material
mammalian
Prior art date
Application number
BR0111726-2A
Other languages
English (en)
Inventor
Bengt Sandberg
Scott Wilbur
Rune Nilsson
Original Assignee
Mitra Medical Technology Ab
Dept Of Radiation Oncology Uni
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from SE0002287A external-priority patent/SE0002287D0/xx
Application filed by Mitra Medical Technology Ab, Dept Of Radiation Oncology Uni filed Critical Mitra Medical Technology Ab
Publication of BR0111726A publication Critical patent/BR0111726A/pt

Links

Classifications

    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
    • B01D15/08—Selective adsorption, e.g. chromatography
    • B01D15/26—Selective adsorption, e.g. chromatography characterised by the separation mechanism
    • B01D15/38—Selective adsorption, e.g. chromatography characterised by the separation mechanism involving specific interaction not covered by one or more of groups B01D15/265 and B01D15/30 - B01D15/36, e.g. affinity, ligand exchange or chiral chromatography
    • B01D15/3804—Affinity chromatography
    • B01D15/3823—Affinity chromatography of other types, e.g. avidin, streptavidin or biotin

Landscapes

  • Chemical & Material Sciences (AREA)
  • Analytical Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • External Artificial Organs (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

"DERIVADOS DE BIOTINA". Um método para o condicionamento de um dispositivo extracorpóreo é descrito, bem como método para extração extracorpórea de material tóxico de fluidos de corpo de mamífero com relação a diagnose ou tratamento de uma condição ou doença de mamífero, em cujos métodos reagentes tendo a capacidade de extrair material tóxico de fluidos de corpo de mamífero são envolvidos, e um dispositivo extracorpóreo compreendendo o referido reagente.
BR0111726-2A 2000-06-16 2001-06-18 Derivados de biotina BR0111726A (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
SE0002287A SE0002287D0 (sv) 2000-06-16 2000-06-16 Biotinderivat
US21662500P 2000-07-07 2000-07-07
PCT/SE2001/001374 WO2001095857A2 (en) 2000-06-16 2001-06-18 Reusable extracorporeal colums loaded with ligand-dibiotin conjugates

Publications (1)

Publication Number Publication Date
BR0111726A true BR0111726A (pt) 2003-05-27

Family

ID=26655149

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0111726-2A BR0111726A (pt) 2000-06-16 2001-06-18 Derivados de biotina

Country Status (14)

Country Link
EP (1) EP1289563B1 (pt)
JP (1) JP2004503299A (pt)
CN (1) CN1457260A (pt)
AT (1) ATE469661T1 (pt)
AU (2) AU7476101A (pt)
BR (1) BR0111726A (pt)
CA (1) CA2412495C (pt)
DE (1) DE60142286D1 (pt)
HU (1) HUP0401953A3 (pt)
IL (1) IL153449A0 (pt)
MX (1) MXPA02012438A (pt)
NO (1) NO20025931L (pt)
PL (1) PL359328A1 (pt)
WO (1) WO2001095857A2 (pt)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SI1813614T1 (sl) * 2006-01-25 2012-01-31 Sanofi 174 Citotoksična sredstva, ki obsegajo nove tomajmicinske derivate
AU2008322998B2 (en) 2007-11-12 2013-10-03 Chreto Aps Dual affinity polypeptides for purification
MX345538B (es) * 2011-05-27 2017-02-03 Ambrx Inc Composiciones que contienen, metodos que incluyen, y usos de derivados de dolastatina enlazados a aminoacidos no naturales.
PE20140784A1 (es) 2011-05-27 2014-07-03 Ambrx Inc Composiciones que contienen, metodos que involucran, y usos de derivados de dolastatina unidos a aminoacidos no naturales
JP6096371B2 (ja) 2014-02-18 2017-03-15 サヴィッド・セラピューティックス株式会社 ビオチン改変体、ストレプトアビジン変異体およびそれらの利用
CN106166311B (zh) * 2016-08-30 2018-07-13 张小曦 一种血浆净化系统及其应用
EP3562842A1 (en) * 2016-12-27 2019-11-06 H. Hoffnabb-La Roche Ag Novel biotin-specific monoclonal antibody and use thereof
KR20210126136A (ko) 2016-12-27 2021-10-19 에프. 호프만-라 로슈 아게 신규한 비오틴-특이적 단일클론 항체 및 그 용도
US11442066B2 (en) 2017-02-17 2022-09-13 Mitsui Chemicals, Inc Method for identifying drug-discovery target protein for development of antibody drug, and method for producing antibody against target protein

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9100142L (sv) * 1991-01-17 1992-07-18 Bengt Sandberg En metod och ett system foer foerbaettrad in vivo reducering av diagnostiska och/eller terapeutiska substanser medelst extrakorporeal borttagning, och anvaendandet av naemnda substanser foer detta aendamaal
US5482698A (en) * 1993-04-22 1996-01-09 Immunomedics, Inc. Detection and therapy of lesions with biotin/avidin polymer conjugates
JP3441530B2 (ja) * 1994-10-03 2003-09-02 株式会社セルシード 温度応答型分離材料及びその製造方法
JP3300583B2 (ja) * 1995-11-10 2002-07-08 幹男 中山 抗原又は抗体の検出シート、検出キット及び検出方法
AU2052497A (en) * 1996-02-08 1997-08-28 Board Of Regents Of The University Of Washington, The Biotin-containing compounds, biotinylation reagents and methods

Also Published As

Publication number Publication date
ATE469661T1 (de) 2010-06-15
CN1457260A (zh) 2003-11-19
NO20025931L (no) 2003-02-14
JP2004503299A (ja) 2004-02-05
CA2412495A1 (en) 2001-12-20
NO20025931D0 (no) 2002-12-11
HUP0401953A2 (hu) 2004-12-28
WO2001095857A3 (en) 2002-03-28
WO2001095857A2 (en) 2001-12-20
MXPA02012438A (es) 2004-09-06
EP1289563B1 (en) 2010-06-02
AU2001274761B2 (en) 2005-06-16
EP1289563A2 (en) 2003-03-12
DE60142286D1 (de) 2010-07-15
HUP0401953A3 (en) 2005-06-28
PL359328A1 (en) 2004-08-23
AU7476101A (en) 2001-12-24
CA2412495C (en) 2011-02-01
IL153449A0 (en) 2003-07-06

Similar Documents

Publication Publication Date Title
BR0016066A (pt) Compostos e métodos para tratamento e diagnóstico de infecção clamidial
BRPI0515758A (pt) dispositivo de ensaio de diagnóstico
ATE440629T1 (de) Kanüleneinführungssystem
BR9916020A (pt) Compostos e métodos para o tratamento e diagnóstico de infecção por chlamydia
MXPA04000062A (es) Miembros de drenaje extensibles para conectar a tierra la proteccion por interferencia electromagnetica/interferencia por radiofrecuencia.
BRPI0411013A (pt) implante para uso na fusão de estruturas ósseas adjacentes, método de tratar um organismo para promover fusão de estruturas ósseas adjacentes e sistema para uso na fusão de estruturas ósseas adjacentes
PT1157041E (pt) Anticorpos para terapia e diagnostico de cancro
BR0316111A (pt) Métodos para diagnosticar rcc e outros tumores sólidos
EP1373567A4 (en) DETECTION OF HIGH-THROUGHPUT METHYL-GATION SEQUENCES FOR THE DIAGNOSIS OF MALIGNANT CELLS
PL365951A1 (pl) Związki oraz sposoby leczenia i diagnozowania infekcji Chlamydia
ATE442592T1 (de) Detektion und/oder beobachtung von synuclein- assoziierten krankheiten
BRPI0413350A (pt) dispositivo e métodos para coleta de amostra de fluido biológico e tratamento de componentes selecionados
AU7494701A (en) Nrg-2 nucleic acid molecules, polypeptides, and diagnostic and therapeutic methods
WO2006086561A3 (en) Neutralizing monoclonal antibodies against severe acute respiratory syndrome-associated coronavirus
BR9815866A (pt) Dispositivo para a coleta e preparação inicial de amostras de células contendo dna, processos para a coleta de uma amostra de células contendo dna e para a tipificação de populações animais e uso do dispositivo
BR0110091A (pt) Composições e processos para terapia e diagnóstico de câncer de mama
BR0111726A (pt) Derivados de biotina
DE50207866D1 (de) Verwendung löslicher cytokeratin-1-fragmente in diagnostik
SE0002287D0 (sv) Biotinderivat
ATE349533T1 (de) Zusammensetzung zur diagnose und behandlung von herpes simplex virusinfektionen
BR0316599A (pt) Agentes de alvejamento anti-linfoma com funções efetoras e de afinidade ligadas por um reagente trifuncional
PT1242825E (pt) Extraccao de lipoproteinas a partir de fluidos corporais
DE60037676D1 (de) Verfahren zur diagnose von rickettsia pulicis
WO2003061622A3 (de) Verfahren und vorrichtumg tum einbringen von lebenden zellen in eine biologische körperflüssigkeit
WO2003056341A3 (de) Verfahren zur diagnose von brustkrebserkrankungen, zugehörige peptide und deren verwendungen

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 7A E 8A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 DA RPI 2016 DE 25/08/2009.

B15K Others concerning applications: alteration of classification

Ipc: B01D 15/38 (2006.01)